FDA approves Sanofi and Regeneron ' s skin cancer med

The imunotherapy Libtayo can treat patients with particular kinds of cutaneous squamous cell carcinoma.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news